New Alzheimer’s clinical trials centre opens in Aberdeen

Scottish Brain Sciences (SBS) has opened a state-of-the-art clinical research centre at ONE BioHub, Aberdeen, expanding access to early-phase Alzheimer’s trials across north-east Scotland. The new facility complements SBS’s existing hubs in Edinburgh and St Andrews, strengthening Scotland’s life sciences ecosystem.

The Aberdeen centre will enable precision trials, early detection studies, and advanced assessments for people with Alzheimer’s or memory concerns. By integrating with ONE BioHub, SBS benefits from flexible lab and office space, tailored business support, and links to universities, NHS Grampian, and investors, enabling rapid scaling of operations.

Professor Craig Ritchie, CEO and Founder, said: “The people of the north-east deserve early access to breakthroughs in brain health and dementia research. This new site ensures participants can contribute to discoveries that could transform Alzheimer’s care.”

SBS joins a growing network of research-driven companies at ONE BioHub, including NovaBiotics and Genomes.io. The expansion reflects Scotland’s commitment to advancing innovative brain health research, supporting both scientific development and regional life sciences growth.

Dr Deborah O’Neil OBE FRSE, Chair, ONE Life Sciences and BioAberdeen, added: “SBS’s focus on neurological conditions enhances our life sciences cluster and demonstrates the impact of integrating clinical research with scalable lab infrastructure.”

More information online